• Days
  • Hours
  • Minutes
  • Seconds
Welcome Message

Dear Colleagues,

We look forward to welcoming you to “The 14th Annual Case-Based Approach to Controversies in Cardiovascular Diseases” on 2 & 3 March 2024 in Dubai, the United Arab Emirates.

Cardiovascular medicine continues to rapidly evolve as research studies and clinical trials continually expand the evidence base related to treatment strategies for patients with cardiovascular disease (CVD). Rapid advancement of new devices, new technologies and new medical options have resulted in many changes and updates regarding management of CVD. The volume and complexity of data generated combined with expanding technologies can make it difficult for busy clinicians to remain up to date regarding diagnosis and treatment.

To fill this educational need, this conference co-sponsored by Cleveland Clinic and Mayo Clinic, will provide an in-depth review and analysis of current state-of-the-art practices in cardiovascular medicine. All sessions will be presented in a “real world” case-based format which encourages participation and debate between the faculty and attendees.

This program is targeted to all healthcare professionals involved in managing patients with cardiovascular diseases, including cardiologists, cardiac surgeons, residents, fellows, and nurses.
Alongside the scientific session, there will be an exhibit, providing attendees with exposure to the most cutting-edge technologies, resources, and treatment solutions in the field of cardiovascular medicine.

We look forward to welcoming you to Dubai in March 2024.

Course Directors
Walid Saliba, MD
Joseph Maalouf, MD
Wael Al Mahmeed, MD

US Organizing Committee
Katherine Hoercher, RN
Wael Jaber, MD

Supported by

Scientific Collaborator


Faisal Bakaeen, MD

Leslie Cho, MD

Wael Jaber, MD

Katherine Hoercher, RN

Venu Menon, MD

Shady Nakhla, MD

Walid Saliba, MD

Leonardo Rodriguez, MD

Joseph Maalouf, MD

Amy Pollak, MD

Peter Pollak, MD

Omar Abou Ezzeddine, MD

Juan Crestanello, MD

Firas Al Badarin, MD

Mohamed Al Jaabari, MD

Wael Al Mahmeed, MD

Feras Badeer, MD

Mohamad Magdi, MD

Dima Quraini-01

Dima Quraini, MD

Bernard Abi Saleh, MD

Ghaliah Al Mohani, MD

Nooshin Bazargani, MD

Zafar Khan, MD

Mario Nijeim, MD

Abdullah Shebab, MD

Hadi Skouri, MD

Scientific Program

Why You Should Attend?

  • Gain practical takeaways on how to reduce cardiovascular risks with the management of hyperlipidemia, obesity, and diet
  • Enhance your clinical and management skills in the treatment of CAD and structural heart disease
  • Explore the latest updates and guidelines in the management of AFib, VT and Heart Failure
  • Hear from multiple perspectives in a case-based format – clinical cardiology, interventional cardiology, cardiac surgery, and cardiovascular imaging – throughout the course

Learning Objectives

  • Define and describe current strategies for the prevention and management of hyperlipidemia, hypertension and cardiovascular protection with Type 2 diabetes.
  • Critically appraise practical applications for the management of tricuspid disease and degenerative mitral regurgitation (MR), including the role of guideline-directed medical therapy (GDMT) and surgical techniques for MR.
  • Analyze the clinical applications and treatments for the management of aortic valve disease.
  • Describe management strategies for new-onset AFib, including interventional options for stroke risk.
  • Apply current guideline recommendations for the treatment of heart failure and cardiomyopathy, including the diagnosis and management of hypertrophic cardiomyopathy and amyloid
  • Examine management strategies for simple and complex CAD

Sessions at a Glance

  • Essentials of Coronary Artery Disease
  • Structural Heart Disease
  • Heart Failure and Critical Care Cardiology
  • Contemporary Management of AF
  • Test Your Skills with EKG and Imaging Cases

Target Audience

  • Cardiologists & Cardiac Surgeons
  • Fellows and Residents in Cardiovascular and Cardiac Surgery training programs
  • Nurses, Physician Assistants and other Allied Health Professionals involved in the care of cardiovascular patients
  • Medical students with an interest in Cardiovascular Medicine
  • Internists & General Practitioners


Take a tour to discover The 14th Annual Case-Based Approach to Controversies in Cardiovascular Diseases

Gold Sponsors
Titanium Sponsors

Enhance your brand position and increase your exposure by driving real value. Ensure your company stands out from the crowd by taking up one or more of these value-added opportunities!

Sponsorship of the 14th Annual Case-Based Approach to Controversies in Cardiovascular Diseases provides an excellent opportunity for companies operating within this exciting field to explore the market and interact to build lasting relationships with current and prospective clients at all levels and segments – corporate and government departments.

Meeting your target audience face-to-face
Direct selling to serious buyers in an active buying mode
Building prospect databases
Generating high-quality sales leads
Building relationships with existing customers
Demonstrating products/services
Generating media exposure
Building brand awareness
Launching new products/ services
Positioning your company as a market leader
Targeting, testing, and developing new markets
Conducting market research
Identifying and recruiting new distributors or partners
Networking with industry peers

Exhibiting at the 14th Annual Case-Based Approach to Controversies in Cardiovascular Diseases multiple benefits to your company, including providing a comprehensive platform for targeted promotion and brand exposure where leading members of the Orthopaedic Surgery and related medicine fields interact to encourage networking and educational opportunities, and develop its future. Showcase your products to leading experts and professionals from both corporate and governmental departments as well as allied health specialists practicing Orthopaedic Surgery related medicine.

Booking is on a first-come-first-served basis. A trade exhibition covering pharmaceutical products, diagnostics and lab tests, lab ware, medical equipment, and instruments, will be organized during the conference at the same venue.

Media Partners
Social Media Wall
2024 Photo Gallery
2024 Video Gallery
Contact us